Abeona Therapeutics, Inc. (ABEO)
6.075
-0.02
(-0.25%)
USD |
NASDAQ |
Aug 24, 16:00
6.075
0.00 (0.00%)
After-Hours: 20:00
Abeona Therapeutics Shareholders Equity (Quarterly) : 128.06M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 128.06M |
| March 31, 2026 | 144.94M |
| December 31, 2025 | 159.22M |
| September 30, 2025 | 171.23M |
| June 30, 2025 | 163.58M |
| March 31, 2025 | 41.40M |
| December 31, 2024 | 44.03M |
| September 30, 2024 | 45.77M |
| June 30, 2024 | 73.24M |
| March 31, 2024 | -8.881M |
| December 31, 2023 | 14.83M |
| September 30, 2023 | 22.04M |
| June 30, 2023 | 9.345M |
| March 31, 2023 | 18.74M |
| December 31, 2022 | 26.76M |
| September 30, 2022 | 15.41M |
| June 30, 2022 | 20.09M |
| March 31, 2022 | 31.44M |
| December 31, 2021 | 51.38M |
| September 30, 2021 | 79.74M |
| June 30, 2021 | 84.09M |
| March 31, 2021 | 94.39M |
| December 31, 2020 | 102.55M |
| September 30, 2020 | 115.11M |
| June 30, 2020 | 121.05M |
| Date | Value |
|---|---|
| March 31, 2020 | 132.38M |
| December 31, 2019 | 178.43M |
| September 30, 2019 | 96.05M |
| June 30, 2019 | 107.16M |
| March 31, 2019 | 117.79M |
| December 31, 2018 | |
| September 30, 2018 | 150.24M |
| June 30, 2018 | 160.91M |
| March 31, 2018 | 169.20M |
| December 31, 2017 | 170.10M |
| September 30, 2017 | 89.88M |
| June 30, 2017 | 89.08M |
| March 31, 2017 | 95.71M |
| December 31, 2016 | 99.10M |
| September 30, 2016 | 63.48M |
| June 30, 2016 | 61.48M |
| March 31, 2016 | 65.66M |
| December 31, 2015 | 67.72M |
| September 30, 2015 | 73.07M |
| June 30, 2015 | 59.95M |
| March 31, 2015 | 3.159M |
| December 31, 2014 | 4.816M |
| September 30, 2014 | -30.36M |
| June 30, 2014 | -28.40M |
| March 31, 2014 | -15.49M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 705.78M |
| Forum Markets, Inc. | 127.80M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 179.51M |
| Total Liabilities (Quarterly) | 51.45M |
| Debt to Equity Ratio | 0.1552 |
| Current Ratio | 6.635 |
| Net Debt Paydown Yield | 0.23% |